Compare Cardinal Health Inc (CAH) vs Alphabet Inc Class A (GOOGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Alphabet Inc Class A — how do they compare? Cardinal Health Inc trades at $224.88 (market cap $53.89B), while Alphabet Inc Class A trades at $370.25 (market cap $4.37T). The key difference: Alphabet Inc Class A is far larger — about 81.1× Cardinal Health Inc's market cap, and Cardinal Health Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| CAH | GOOGL | |
|---|---|---|
Market Cap | $53.89B | $4.37T |
Sector | Health | Media |
52-Week High | $239.71 | $402.62 |
52-Week Low | $146.04 | $182.00 |
Enterprise Value | $58.87B | $4.34T |
Dividend Yield | 0.89% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Alphabet (GOOGL) trades at $370.92, up 5.22% over the past day, with a neutral technical signal. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $5.11 significantly exceeding the $2.64 estimate. Revenue grew to $402.84 billion in 2025, up from $350.0 billion in 2024, while net income increased to $132.17 billion. Analyst sentiment remains overwhelmingly positive, with 85% recommending a buy and a consensus price target of $431.78.
The outlook for GOOGL is positive, driven by robust revenue growth, expanding profit margins, and leadership in AI and cloud infrastructure. Key risks include regulatory scrutiny, competitive pressures in digital advertising, and market volatility. The stock presents a compelling opportunity for growth investors, supported by strong fundamentals and bullish analyst coverage, though investors should be mindful of execution and macroeconomic challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →
